Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Anbio Biotechnology (NNNN)

3.6800 +0.0950 (+2.65%)
At close: November 4 at 4:00:00 PM EST
Trade NNNN on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
8,646.8440
8,646.8440
8,185.1460
6,711.9900
23,544.6520
Cost of Revenue
1,103.6820
1,103.6820
2,299.7620
3,351.1210
10,980.8470
Gross Profit
7,543.1620
7,543.1620
5,885.3840
3,360.8690
12,563.8050
Operating Expense
1,775.4220
1,775.4220
3,890.0170
1,399.9400
2,368.2170
Operating Income
5,767.7400
5,767.7400
1,995.3670
1,960.9290
10,195.5880
Net Non Operating Interest Income Expense
142.0230
142.0230
337.5110
165.3360
34.2460
Other Income Expense
493.7000
493.7000
39.9640
127.4440
-218.6570
Pretax Income
6,403.4630
6,403.4630
2,372.8420
2,253.7090
10,011.1770
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
6,403.4630
6,403.4630
2,372.8420
2,253.7090
10,011.1770
Diluted NI Available to Com Stockholders
6,403.4630
6,403.4630
2,372.8420
2,253.7090
10,011.1770
Basic EPS
0.15
--
0.05
0.02
0.07
Diluted EPS
0.15
--
0.05
0.01
0.07
Basic Average Shares
43,672.0220
--
43,891.2000
143,891.2000
143,891.2000
Diluted Average Shares
43,672.0220
--
43,891.2000
187,782.4000
143,891.2000
Total Operating Income as Reported
5,767.7400
5,767.7400
1,995.3670
1,960.9290
10,195.5880
Total Expenses
2,879.1040
2,879.1040
6,189.7790
4,751.0610
13,349.0640
Net Income from Continuing & Discontinued Operation
6,403.4630
6,403.4630
2,372.8420
2,253.7090
10,011.1770
Normalized Income
5,909.9010
5,909.9010
2,352.3730
2,134.2900
10,273.3960
Interest Income
142.0230
142.0230
337.5110
165.3360
42.2450
Interest Expense
--
--
0
0
7.9990
Net Interest Income
142.0230
142.0230
337.5110
165.3360
34.2460
EBIT
5,767.7400
5,767.7400
1,995.3670
1,960.9290
10,019.1760
EBITDA
5,767.7400
5,767.7400
1,995.3670
1,972.9880
10,025.4280
Reconciled Cost of Revenue
1,103.6820
1,103.6820
2,299.7620
3,351.1210
10,980.8470
Reconciled Depreciation
--
--
0
12.0590
6.2520
Net Income from Continuing Operation Net Minority Interest
6,403.4630
6,403.4630
2,372.8420
2,253.7090
10,011.1770
Total Unusual Items Excluding Goodwill
493.5620
493.5620
20.4690
119.4190
-262.2190
Total Unusual Items
493.5620
493.5620
20.4690
119.4190
-262.2190
Normalized EBITDA
5,274.1780
5,274.1780
1,974.8980
1,853.5690
10,287.6470
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 2/19/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: